Product Information
CLINDAMYCIN HCL 300 MG CAPSULE is a generic product labeled by Aurobindo Pharma Limited, priced at $0.1684 per EA under NDC 65862018601. Its NADAC has been published 569 times since Nov 28, 2013.
FDA first approved this application on Aug 26, 2009. Its Orange Book therapeutic-equivalence code is AB — FDA rates it therapeutically equivalent to (substitutable for) its reference product.
Strength
300 mg/1
Manufacturer
Aurobindo Pharma LimitedNDC
65862018601
Classification
Generic
Dosage Form
CAPSULE
Route
ORAL
Effective Date
8/19/2026
Active Ingredients
CLINDAMYCIN HYDROCHLORIDEApproval Type
Generic (ANDA)
FDA Application
ANDA065442FDA Approved
8/26/2009
TE Code
AB
On Market Since
8/26/2009
Pharmacological Classes
Price Statistics
The NADAC for CLINDAMYCIN HCL 300 MG CAPSULE has been published 569 times since Nov 28, 2013, and over the history we have for it it has declined 30.3%. The table below summarizes its recorded NADAC range and movement.
| Current price | $0.1684 per EA |
|---|---|
| All-time high | $0.3115 (Nov 13, 2019) |
| All-time low | $0.1674 (Nov 20, 2024) |
| 52-week high | $0.1895 |
| 52-week low | $0.1680 |
| Median price | $0.2518 |
| Average price | $0.2401 |
| Largest weekly change | +33.6% (Aug 21, 2024) |
| Weeks tracked | 569 |
| Tracking since | Nov 28, 2013 |
Generic Alternatives
The matcher finds 4 manufacturers offering a NADAC-published product with this drug's active ingredient and strength in a comparable dosage form (cheapest from each manufacturer, up to 10 shown below). None of the shown alternatives sit below the current price. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.
Related Drugs
Same classification
Frequently asked questions
What is the NADAC price of CLINDAMYCIN HCL 300 MG CAPSULE?
The current National Average Drug Acquisition Cost (NADAC) for CLINDAMYCIN HCL 300 MG CAPSULE, manufactured by Aurobindo Pharma Limited, is $0.1684 per EA (NDC 65862018601), effective Aug 19, 2026.
How has the price of CLINDAMYCIN HCL 300 MG CAPSULE changed over time?
Over the history we have for it, the NADAC for CLINDAMYCIN HCL 300 MG CAPSULE has declined 30.3%. It has been tracked across 569 weekly CMS publications since Nov 28, 2013.
What are the highest and lowest recorded NADAC prices for CLINDAMYCIN HCL 300 MG CAPSULE?
Since Nov 28, 2013, the NADAC for CLINDAMYCIN HCL 300 MG CAPSULE has ranged from a low of $0.1674 (Nov 20, 2024) to a high of $0.3115 (Nov 13, 2019), with a median of $0.2518 per EA.
Are there cheaper alternatives to CLINDAMYCIN HCL 300 MG CAPSULE?
4 manufacturers publish a NADAC-priced product with the same active ingredient and strength as CLINDAMYCIN HCL 300 MG CAPSULE in a comparable dosage form, but none are currently priced below it.
Who manufactures CLINDAMYCIN HCL 300 MG CAPSULE?
CLINDAMYCIN HCL 300 MG CAPSULE (NDC 65862018601) is labeled by Aurobindo Pharma Limited, and CMS classifies it as a generic product.